See every side of every news story
Published United StatesUpdated

Basis Medical’s Seclusion Catheter for Superficial Vein Reflux Receives FDA Clearance - Endovascular Today

Summary by Endovascular Today
March 7, 2025—Basis Medical recently announced that its Seclusion catheter for the treatment of superficial vein reflux has received FDA 510(k) clearance. According to the company, Seclusion is an endovenous chemical ablation device designed to provide a safe, comfortable, and clinically effective solution for patients with superficial vein reflux and chronic venous insufficiency. Basis Medical stated that the Seclusion catheter is a dual-balloo…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Endovascular Today broke the news in on Friday, March 7, 2025.
Sources are mostly out of (0)

You have read 1 out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

Our use of cookies
Unlike other news sites, we do not share or sell your data to third-parties for targeted ads.
By continuing to use our application or website, you agree to our Terms of Service and Privacy Policy.